Q96LZ3
PR
Gene name |
PPP3R2 (CBLP, PPP3RL) |
Protein name |
Calcineurin subunit B type 2 |
Names |
Calcineurin B-like protein, CBLP, Calcineurin BII, CNBII, PPP3R1-like, Protein phosphatase 2B regulatory subunit 2, Protein phosphatase 3 regulatory subunit B beta isoform |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:5535 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q96LZ3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q96LZ3-F1 | Predicted | AlphaFoldDB |
165 variants for Q96LZ3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs774345802 CA5163007 |
2 | G>* | No |
ClinGen ExAC gnomAD |
|
|
CA374269838 rs1229246164 |
3 | N>I | No |
ClinGen gnomAD |
|
|
rs1306296472 CA374269827 |
4 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
rs1306296472 CA374269826 |
4 | E>Q | No |
ClinGen TOPMed gnomAD |
|
|
rs1409335296 CA374269808 |
5 | A>D | No |
ClinGen gnomAD |
|
|
rs1166309236 CA374269811 |
5 | A>T | No |
ClinGen TOPMed |
|
|
rs1349910106 CA374269798 |
6 | S>C | No |
ClinGen TOPMed |
|
|
rs1336161046 CA374269752 |
9 | A>G | No |
ClinGen gnomAD |
|
|
CA5163004 rs375935503 |
10 | E>D | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA197298845 CA5163003 rs374058531 |
11 | M>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1410200833 CA374269732 |
11 | M>L | No |
ClinGen TOPMed |
|
|
CA374269689 rs1371106344 |
14 | H>Y | No |
ClinGen TOPMed |
|
|
rs953717988 CA374269619 |
18 | D>E | No |
ClinGen TOPMed |
|
|
CA374269617 rs1472868875 |
19 | E>K | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs146408489 CA5162999 |
20 | I>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1212935879 CA374269584 |
21 | K>E | No |
ClinGen gnomAD |
|
|
CA5162998 rs751096597 |
22 | R>K | No |
ClinGen ExAC gnomAD |
|
|
rs1564121703 CA374269541 |
24 | G>D | No |
ClinGen Ensembl |
|
|
rs1209540092 CA374269535 |
25 | R>G | No |
ClinGen gnomAD |
|
|
CA374269525 rs1220597185 |
25 | R>S | No |
ClinGen TOPMed |
|
|
CA197298795 rs985323161 |
26 | R>S | No |
ClinGen TOPMed gnomAD |
|
|
rs1588240768 CA374269504 |
27 | F>V | No |
ClinGen Ensembl |
|
|
CA5162996 rs542836480 |
29 | K>R | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs750777610 CA5162994 |
31 | D>E | No |
ClinGen ExAC |
|
|
rs765721292 CA5162993 |
32 | L>F | No |
ClinGen ExAC gnomAD |
|
|
rs762071489 CA5162992 |
33 | D>Y | No |
ClinGen ExAC gnomAD |
|
|
CA374269403 rs1564121687 |
34 | K>E | No |
ClinGen Ensembl |
|
|
rs576097834 CA5162990 |
36 | G>E | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1445752266 CA374269376 |
36 | G>R | No |
ClinGen TOPMed gnomAD |
|
|
rs576097834 CA374269369 |
36 | G>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1413726400 CA374269353 |
38 | L>P | No |
ClinGen Ensembl |
|
|
CA197298711 rs143999871 |
39 | S>R | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP NCI-TCGA TOPMed gnomAD |
|
rs760800259 CA5162987 |
39 | S>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA5162986 rs775485051 |
40 | V>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA374269323 rs1443460162 |
41 | E>Q | No |
ClinGen TOPMed |
|
|
rs1588240707 TCGA novel CA374269281 |
43 | F>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
NCI-TCGA ClinGen Ensembl |
|
CA374269274 rs1564121654 |
44 | M>L | No |
ClinGen Ensembl |
|
|
rs553900338 CA5162984 |
44 | M>T | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA5162983 rs772939200 |
45 | S>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1327958202 CA374269251 |
46 | L>Q | No |
ClinGen TOPMed |
|
|
rs906528742 CA197298679 |
48 | E>D | No |
ClinGen TOPMed gnomAD |
|
|
CA374269228 rs1325683448 |
48 | E>G | No |
ClinGen Ensembl |
|
|
rs151333989 CA5162980 |
48 | E>K | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs151333989 CA5162981 |
48 | E>Q | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs142403692 CA5162977 |
49 | L>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1466578003 CA374269217 |
49 | L>Q | No |
ClinGen gnomAD |
|
|
rs142403692 CA5162976 |
49 | L>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs746497872 CA5162975 |
50 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs577767900 CA5162974 |
50 | R>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA374269212 rs746497872 |
50 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs758927110 CA5162973 |
52 | N>D | No |
ClinGen ExAC gnomAD |
|
|
rs751936797 CA5162972 |
52 | N>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5162970 rs201878659 |
53 | P>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
|
rs201878659 CA5162971 |
53 | P>Q | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs867279328 CA197298644 |
53 | P>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
rs1298300082 CA374269134 |
56 | R>Q | No |
ClinGen TOPMed gnomAD |
|
|
rs1378306586 CA374269136 |
56 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
CA374269123 rs1436991419 |
57 | R>P | No |
ClinGen gnomAD |
|
|
rs754217594 CA5162968 |
58 | V>G | No |
ClinGen ExAC gnomAD |
|
|
rs1362847727 CA374269117 |
58 | V>L | No |
ClinGen gnomAD |
|
|
CA374269085 rs148782154 |
60 | D>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA5162966 rs756326986 |
61 | V>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs752778285 CA5162965 |
62 | F>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs767514182 CA5162964 |
63 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs1391421876 CA374269033 |
64 | T>I | No |
ClinGen TOPMed |
|
|
CA5162963 rs762817577 |
65 | D>H | No |
ClinGen ExAC gnomAD |
|
|
CA197298500 rs267602059 |
66 | G>D | No |
ClinGen Ensembl |
|
|
CA5162962 rs202237297 |
66 | G>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA5162961 rs202237297 |
66 | G>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 67 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1248714701 CA374268972 |
69 | E>* | No |
ClinGen gnomAD |
|
|
CA374268961 rs1219434998 |
70 | V>L | No |
ClinGen TOPMed gnomAD |
|
|
rs1219434998 CA374268957 |
70 | V>M | No |
ClinGen TOPMed gnomAD |
|
|
rs904678937 CA197298480 |
71 | D>Y | No |
ClinGen TOPMed gnomAD |
|
|
CA5162956 rs768315406 |
72 | F>L | No |
ClinGen ExAC gnomAD |
|
|
CA374268908 rs1227024419 |
73 | K>R | No |
ClinGen TOPMed |
|
|
rs144342934 CA374268839 |
78 | G>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs144342934 CA5162955 |
78 | G>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs775007740 CA5162954 |
81 | Q>* | No |
ClinGen ExAC gnomAD |
|
|
CA374268790 rs1296623488 |
82 | F>L | No |
ClinGen TOPMed gnomAD |
|
|
rs771714332 CA5162953 |
83 | S>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs745440244 CA5162952 |
83 | S>N | No |
ClinGen ExAC gnomAD |
|
|
CA374268769 rs1291491534 |
84 | V>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA5162950 rs140002593 |
85 | K>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs778025730 CA5162948 |
85 | K>N | No |
ClinGen ExAC gnomAD |
|
|
CA5162947 rs756306363 |
86 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5162945 rs767516711 |
88 | E>K | No |
ClinGen ExAC gnomAD |
|
|
CA5162944 rs267602058 |
89 | E>K | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 93 | R>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA5162943 rs751694822 |
93 | R>T | No |
ClinGen ExAC gnomAD |
|
|
rs765137583 CA5162942 |
94 | F>S | No |
ClinGen ExAC gnomAD |
|
|
rs1228924887 CA374268619 |
95 | A>T | No |
ClinGen gnomAD |
|
|
rs1252638845 CA374268611 |
95 | A>V | No |
ClinGen TOPMed gnomAD |
|
|
CA197298332 rs761688744 |
96 | F>I | No |
ClinGen ExAC gnomAD |
|
|
CA5162941 rs761688744 |
96 | F>L | No |
ClinGen ExAC gnomAD |
|
|
rs569559919 CA5162938 |
100 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
|
rs201136759 CA5162937 |
101 | M>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs201136759 CA5162936 |
101 | M>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374268510 rs1428282686 |
102 | D>E | No |
ClinGen TOPMed |
|
|
rs555766318 CA197298251 |
106 | Y>* | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA5162933 rs771520274 |
106 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs778138570 CA5162931 |
107 | I>F | No |
ClinGen ExAC gnomAD |
|
|
rs770055637 CA5162930 |
109 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs1564121492 CA374268406 |
110 | G>E | No |
ClinGen Ensembl |
|
|
rs1337311300 CA374268410 |
110 | G>R | No |
ClinGen Ensembl |
|
|
CA374268383 rs1161249912 |
112 | L>I | No |
ClinGen TOPMed |
|
| TCGA novel | 115 | V>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs781377759 CA5162928 |
117 | K>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5162927 rs755241988 |
118 | M>I | No |
ClinGen ExAC gnomAD |
|
|
rs1381709595 CA374268306 |
118 | M>V | No |
ClinGen TOPMed |
|
| TCGA novel | 119 | M>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs751607120 CA5162926 |
119 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374268270 rs1588240457 |
120 | V>G | No |
ClinGen Ensembl |
|
|
rs536109611 CA5162925 |
120 | V>M | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs1564121470 CA374268238 |
123 | N>I | No |
ClinGen Ensembl |
|
|
rs1564121470 CA374268242 |
123 | N>T | No |
ClinGen Ensembl |
|
|
CA5162924 rs757162006 |
124 | L>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374268221 rs1564121465 |
125 | T>A | No |
ClinGen Ensembl |
|
|
rs1200972717 CA374268216 |
125 | T>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs1200972717 CA374268218 |
125 | T>R | No |
ClinGen gnomAD |
|
|
CA374268197 rs753725526 |
126 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374268184 rs1202597957 |
127 | W>* | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA374268182 rs1202597957 |
127 | W>C | No |
ClinGen gnomAD |
|
|
rs989671822 CA374268192 |
127 | W>G | No |
ClinGen TOPMed |
|
|
rs989671822 CA197298153 |
127 | W>R | No |
ClinGen TOPMed |
|
|
rs1329387569 CA374268163 |
129 | L>F | No |
ClinGen gnomAD |
|
|
rs771888538 CA5162922 |
130 | Q>P | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 133 | V>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA374268111 rs1588240425 |
133 | V>G | No |
ClinGen Ensembl |
|
|
rs1226023557 CA374268118 |
133 | V>I | No |
ClinGen gnomAD |
|
|
rs1588240416 CA374268105 |
134 | D>G | No |
ClinGen Ensembl |
|
|
rs760377198 CA374268108 |
134 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs760377198 CA5162921 |
134 | D>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1588240411 CA374268077 |
136 | T>N | No |
ClinGen Ensembl |
|
|
rs767251662 CA5162919 |
138 | I>N | No |
ClinGen ExAC gnomAD |
|
|
CA374268055 rs767251662 |
138 | I>S | No |
ClinGen ExAC gnomAD |
|
|
CA5162920 rs752591338 |
138 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA374268014 rs1161738334 |
141 | D>E | No |
ClinGen TOPMed gnomAD |
|
|
rs1389625088 CA374268020 |
141 | D>G | No |
ClinGen gnomAD |
|
|
CA5162916 rs770358010 |
143 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5162917 rs773945805 |
143 | D>N | No |
ClinGen ExAC gnomAD |
|
|
CA374267966 rs1416595570 |
145 | D>G | No |
ClinGen gnomAD |
|
|
CA5162914 rs140969417 |
145 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
|
rs1254045172 CA374267953 |
146 | G>E | No |
ClinGen gnomAD |
|
|
rs748438582 CA5162912 |
148 | I>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1364309672 CA374267915 |
149 | S>T | No |
ClinGen TOPMed |
|
|
rs1269621315 CA374267911 |
149 | S>Y | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs781576089 CA5162911 |
150 | F>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA197298059 rs547123769 |
151 | E>Q | No |
ClinGen 1000Genomes |
|
|
rs373748590 CA197298054 |
152 | E>V | No |
ClinGen Ensembl |
|
|
rs1588240358 CA374267861 |
153 | F>I | No |
ClinGen Ensembl |
|
|
CA5162910 rs774775761 |
154 | S>G | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 155 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1323994048 CA374267809 |
157 | V>A | No |
ClinGen gnomAD |
|
|
rs747246148 CA5162909 |
157 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1588240340 CA374267805 |
158 | R>G | No |
ClinGen Ensembl |
|
|
rs113905393 CA197298007 |
159 | D>G | No |
ClinGen Ensembl |
|
|
rs758405374 CA374267743 |
162 | I>M | No |
ClinGen ExAC gnomAD |
|
|
rs1322745186 CA374267739 |
163 | H>Y | No |
ClinGen gnomAD |
|
|
rs376770102 CA5162906 |
165 | K>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs777552418 CA5162905 |
167 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA5162904 rs756120221 |
168 | L>P | No |
ClinGen ExAC gnomAD |
|
|
rs151037849 CA5162902 |
170 | V>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ESP ExAC NCI-TCGA TOPMed gnomAD |
| TCGA novel | 170 | V>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA374267648 rs1412059986 CA374267646 |
171 | V>R | No |
ClinGen TOPMed |
No associated diseases with Q96LZ3
1 regional properties for Q96LZ3
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Thymidylate kinase-like domain | 8 - 196 | IPR039430 |
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| calcineurin complex | A heterodimeric calcium ion and calmodulin dependent protein phosphatase composed of catalytic and regulatory subunits; the regulatory subunit is very similar in sequence to calmodulin. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| protein serine/threonine phosphatase complex | A complex, normally consisting of a catalytic and a regulatory subunit, which catalyzes the removal of a phosphate group from a serine or threonine residue of a protein. |
| sperm mitochondrial sheath | The tightly packed helical sheath of ATP-producing mitochondria restricted to the midpiece of the sperm flagellum. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| calcium ion binding | Binding to a calcium ion (Ca2+). |
| calcium-dependent protein serine/threonine phosphatase regulator activity | Binds to and modulates of the activity of the enzyme calcium-dependent protein serine/threonine phosphatase. |
| phosphatase binding | Binding to a phosphatase. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| calcineurin-mediated signaling | Any intracellular signal transduction in which the signal is passed on within the cell by activation of a transcription factor as a consequence of dephosphorylation by Ca(2+)-activated calcineurin. The process begins with calcium-dependent activation of the phosphatase calcineurin. Calcineurin is a calcium- and calmodulin-dependent serine/threonine protein phosphatase with a conserved function in eukaryotic species from yeast to humans. In yeast and fungi, calcineurin regulates stress signaling and cell cycle, and sporulation and virulence in pathogenic fungi. In metazoans, calcineurin is involved in cell commitment, organogenesis and organ development and immune function of T-lymphocytes. By a conserved mechanism, calcineurin phosphatase activates fungal Crz1 and mammalian NFATc by dephosphorylation and translocation of these transcription factors to the nucleus to regulate gene expression. |
| negative regulation of calcium ion import across plasma membrane | Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion import across plasma membrane. |
| negative regulation of voltage-gated calcium channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of voltage-gated calcium channel activity. |
| penetration of zona pellucida | The infiltration by sperm of the zona pellucida to reach the oocyte. The process involves digestive enzymes from a modified lysosome called the acrosome, situated at the head of the sperm. |
| positive regulation of calcineurin-NFAT signaling cascade | Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade. |
| positive regulation of calcium ion import across plasma membrane | Any process that activates or increases the frequency, rate or extent of calcium ion import across plasma membrane. |
| positive regulation of voltage-gated calcium channel activity | Any process that activates or increases the frequency, rate or extent of voltage-gated calcium channel activity. |
| protein dephosphorylation | The process of removing one or more phosphoric residues from a protein. |
11 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P63099 | PPP3R1 | Calcineurin subunit B type 1 | Bos taurus (Bovine) | PR |
| Q2TBI5 | PPP3R2 | Calcineurin subunit B type 2 | Bos taurus (Bovine) | PR |
| A0AVX7 | TESC | Calcineurin B homologous protein 3 | Gallus gallus (Chicken) | PR |
| Q96BS2 | TESC | Calcineurin B homologous protein 3 | Homo sapiens (Human) | PR |
| P63098 | PPP3R1 | Calcineurin subunit B type 1 | Homo sapiens (Human) | PR |
| Q9JKL5 | Tesc | Calcineurin B homologous protein 3 | Mus musculus (Mouse) | PR |
| Q63810 | Ppp3r1 | Calcineurin subunit B type 1 | Mus musculus (Mouse) | PR |
| P63100 | Ppp3r1 | Calcineurin subunit B type 1 | Rattus norvegicus (Rat) | PR |
| P28470 | Ppp3r2 | Calcineurin subunit B type 2 | Rattus norvegicus (Rat) | PR |
| Q75KU4 | CBL4 | Calcineurin B-like protein 4 | Oryza sativa subsp japonica (Rice) | PR |
| Q7XC27 | CBL1 | Calcineurin B-like protein 1 | Oryza sativa subsp japonica (Rice) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGNEASYPAE | MCSHFDNDEI | KRLGRRFKKL | DLDKSGSLSV | EEFMSLPELR | HNPLVRRVID |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VFDTDGDGEV | DFKEFILGTS | QFSVKGDEEQ | KLRFAFSIYD | MDKDGYISNG | ELFQVLKMMV |
| 130 | 140 | 150 | 160 | ||
| GNNLTDWQLQ | QLVDKTIIIL | DKDGDGKISF | EEFSAVVRDL | EIHKKLVLIV |